Literature DB >> 20054093

Screening histories of invasive breast cancers diagnosed 1989-2006 in the West Midlands, UK: variation with time and impact on 10-year survival.

Gill Lawrence1, Emma O'Sullivan, Olive Kearins, Nancy Tappenden, Kate Martin, Matthew Wallis.   

Abstract

OBJECTIVES: To examine variations in screening status category with time for 20,862 invasive breast cancers diagnosed in the West Midlands between 1989 and 2006, and to provide 10-year relative survival rates for each category.
METHOD: Population-based breast screening was introduced in the West Midlands from 1988. Primary invasive breast cancers diagnosed from 1 April 1989 to 31 March 2006 in women eligible for breast screening were identified from the West Midlands Cancer Intelligence Unit's cancer registration database. A screening status was determined for each case using previously published methodology.
RESULTS: Screening status rates are affected initially by the gradual rollout of the screening programme and more recently by the need to wait for three years before interval cancers and cancers in lapsed and non-attenders can be identified. In the steady-state period 1994-2003, 40.6% of invasive breast cancers were screen-detected, 36.3% were interval cancers and 11.2% were cancers in non-attenders (NA). Ten-year relative survival was 89.6% for screen-detected breast cancers, 73.3% for interval cancers and 51.9% for cancers in NA.
CONCLUSION: The detection of invasive breast cancers by screening has improved over time, with an equivalent reduction in the numbers of interval cancers. This, together with a stable rate of cancers in NA and an improvement in the survival of women with interval cancers, suggests that further improvements in breast cancer mortality can be predicted. International comparisons of interval cancer rates are difficult due to interprogramme differences in the time between screens.

Entities:  

Mesh:

Year:  2009        PMID: 20054093     DOI: 10.1258/jms.2009.009040

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  11 in total

1.  Misplaced criticism of breast screening research.

Authors:  Stephen Duffy
Journal:  J R Soc Med       Date:  2012-02       Impact factor: 5.344

2.  Prognosis in women with interval breast cancer: population based observational cohort study.

Authors:  Mette Kalager; Rulla M Tamimi; Michael Bretthauer; Hans-Olov Adami
Journal:  BMJ       Date:  2012-11-16

3.  Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland.

Authors:  R L Bennett; S J Sellars; S M Moss
Journal:  Br J Cancer       Date:  2011-02-01       Impact factor: 7.640

4.  Explaining the difference in prognosis between screen-detected and symptomatic breast cancers.

Authors:  P C Allgood; S W Duffy; O Kearins; E O'Sullivan; N Tappenden; M G Wallis; G Lawrence
Journal:  Br J Cancer       Date:  2011-05-03       Impact factor: 7.640

5.  A randomised trial of the effect of postal reminders on attendance for breast screening.

Authors:  Prue C Allgood; Anthony J Maxwell; Sue Hudson; Judith Offman; Gillian Hutchison; Cathryn Beattie; Raquel Tuano-Donnelly; Anthony Threlfall; Tina Summersgill; Lesley Bellis; Collette Robinson; Samantha Heaton; Julietta Patnick; Stephen W Duffy
Journal:  Br J Cancer       Date:  2016-01-19       Impact factor: 7.640

6.  Effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trial.

Authors:  Prue C Allgood; Roberta Maroni; Sue Hudson; Judith Offman; Anne E Turnbull; Lesley Peacock; Jim Steel; Geraldine Kirby; Christine E Ingram; Julie Somers; Clare Fuller; Anthony G Threlfall; Rhian Gabe; Anthony J Maxwell; Julietta Patnick; Stephen W Duffy
Journal:  Lancet Oncol       Date:  2017-05-15       Impact factor: 41.316

Review 7.  The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review.

Authors:  M J M Broeders; P Allgood; S W Duffy; S Hofvind; I D Nagtegaal; E Paci; S M Moss; L Bucchi
Journal:  BMC Cancer       Date:  2018-09-03       Impact factor: 4.430

8.  Breast cancer survival and prognosis by screening history.

Authors:  A J Coldman; N Phillips
Journal:  Br J Cancer       Date:  2013-12-03       Impact factor: 7.640

Review 9.  Prevalence of gastrointestinal stromal tumour (GIST) in the United Kingdom at different therapeutic lines: an epidemiologic model.

Authors:  Justyna M Starczewska Amelio; Javier Cid Ruzafa; Kamal Desai; Spiros Tzivelekis; Dominic Muston; Javaria Mona Khalid; Philip Ashman; Andrew Maguire
Journal:  BMC Cancer       Date:  2014-05-24       Impact factor: 4.430

10.  Radiological audit of interval breast cancers: Estimation of tumour growth rates.

Authors:  Emma G MacInnes; Stephen W Duffy; Julie A Simpson; Matthew G Wallis; Anne E Turnbull; Louise S Wilkinson; Keshthra Satchithananda; Rumana Rahim; David Dodwell; Brian V Hogan; Oleg Blyuss; Nisha Sharma
Journal:  Breast       Date:  2020-04-01       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.